740 related articles for article (PubMed ID: 23460013)
41. Adjuvant surgical treatment of nontuberculous mycobacterial lung disease.
Shiraishi Y; Katsuragi N; Kita H; Hyogotani A; Saito MH; Shimoda K
Ann Thorac Surg; 2013 Jul; 96(1):287-91. PubMed ID: 23618520
[TBL] [Abstract][Full Text] [Related]
42. Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.
van Ingen J; Ferro BE; Hoefsloot W; Boeree MJ; van Soolingen D
Expert Rev Anti Infect Ther; 2013 Oct; 11(10):1065-77. PubMed ID: 24124798
[TBL] [Abstract][Full Text] [Related]
43. Cutaneous Infections Due to Nontuberculosis Mycobacterium: Recognition and Management.
Chung J; Ince D; Ford BA; Wanat KA
Am J Clin Dermatol; 2018 Dec; 19(6):867-878. PubMed ID: 30168084
[TBL] [Abstract][Full Text] [Related]
44. Medications and Monitoring in Treatment of Nontuberculous Mycobacterial Pulmonary Disease.
Sawka A; Burke A
Clin Chest Med; 2023 Dec; 44(4):815-828. PubMed ID: 37890918
[TBL] [Abstract][Full Text] [Related]
45. Non-tuberculous mycobacteria in children: muddying the waters of tuberculosis diagnosis.
López-Varela E; García-Basteiro AL; Santiago B; Wagner D; van Ingen J; Kampmann B
Lancet Respir Med; 2015 Mar; 3(3):244-56. PubMed ID: 25773213
[TBL] [Abstract][Full Text] [Related]
46. Disseminated Mycobacterium gordonae infection in a child with cystic fibrosis.
Verma N; Spencer D
Pediatr Pulmonol; 2012 May; 47(5):517-8. PubMed ID: 22028301
[TBL] [Abstract][Full Text] [Related]
47. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
48. [Study on pulmonary lesions in which nontuberculous mycobacteria were detected by percutaneous aspiration--a proposal to add "culture positivity of percutaneous aspiration material" to the bacteriological diagnostic criteria of pulmonary nontuberculous mycobacterial diseases].
Nakahara Y; Mochizuki Y; Kawamura T; Sasaki S; Morimoto A; Mizumori Y; Tsukamoto H; Watanabe E; Yokoyama T
Kekkaku; 2013 Mar; 88(3):283-9. PubMed ID: 23672168
[TBL] [Abstract][Full Text] [Related]
49. Nontuberculous mycobacterial lung diseases.
Taiwo B; Glassroth J
Infect Dis Clin North Am; 2010 Sep; 24(3):769-89. PubMed ID: 20674803
[TBL] [Abstract][Full Text] [Related]
50. [Diagnosis and treatment of atypical mycobacterial infections of the respiratory tract].
Andréjak C; Lescure FX; Schmit JL; Jounieaux V
Rev Mal Respir; 2011 Dec; 28(10):1293-309. PubMed ID: 22152937
[TBL] [Abstract][Full Text] [Related]
51. Identification and drug susceptibility testing for nontuberculous mycobacteria.
Huang WC; Yu MC; Huang YW
J Formos Med Assoc; 2020 Jun; 119 Suppl 1():S32-S41. PubMed ID: 32423573
[TBL] [Abstract][Full Text] [Related]
52. Mycobacterial Characteristics and Treatment Outcomes in Mycobacterium abscessus Lung Disease.
Koh WJ; Jeong BH; Kim SY; Jeon K; Park KU; Jhun BW; Lee H; Park HY; Kim DH; Huh HJ; Ki CS; Lee NY; Kim HK; Choi YS; Kim J; Lee SH; Kim CK; Shin SJ; Daley CL; Kim H; Kwon OJ
Clin Infect Dis; 2017 Feb; 64(3):309-316. PubMed ID: 28011608
[TBL] [Abstract][Full Text] [Related]
53. Drug susceptibility testing of nontuberculous mycobacteria.
van Ingen J; Kuijper EJ
Future Microbiol; 2014; 9(9):1095-110. PubMed ID: 25340838
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease.
Kwon YS; Koh WJ
J Korean Med Sci; 2016 May; 31(5):649-59. PubMed ID: 27134484
[TBL] [Abstract][Full Text] [Related]
55. The Other Nontuberculous Mycobacteria: Clinical Aspects of Lung Disease Caused by Less Common Slowly Growing Nontuberculous Mycobacteria Species.
Yan M; Brode SK; Marras TK
Chest; 2023 Feb; 163(2):281-291. PubMed ID: 36174743
[TBL] [Abstract][Full Text] [Related]
56. Human infections due to nontuberculous mycobacteria: the infectious diseases and clinical microbiology specialists' point of view.
Guglielmetti L; Mougari F; Lopes A; Raskine L; Cambau E
Future Microbiol; 2015; 10(9):1467-83. PubMed ID: 26344005
[TBL] [Abstract][Full Text] [Related]
57. Nontuberculous Mycobacteria-Overview.
Koh WJ
Microbiol Spectr; 2017 Jan; 5(1):. PubMed ID: 28128073
[TBL] [Abstract][Full Text] [Related]
58. Patients with nontuberculous mycobacteria: comparison of updated and previous diagnostic criteria for lung disease.
Epson E; Cassidy M; Marshall-Olson A; Hedberg K; Winthrop KL
Diagn Microbiol Infect Dis; 2012 Sep; 74(1):98-100. PubMed ID: 22795963
[TBL] [Abstract][Full Text] [Related]
59. Analysis of the impact of lung cancer treatment on nontuberculous mycobacterial lung diseases.
Tsuji T; Tsuyuguchi K; Tachibana K; Kimura Y; Kobayashi T; Minomo S; Atagi S; Matsumura A; Hayashi S; Suzuki K
Respir Investig; 2017 Jan; 55(1):45-50. PubMed ID: 28012493
[TBL] [Abstract][Full Text] [Related]
60. Treatment of pulmonary disease caused by non-tuberculous mycobacteria.
van Ingen J
Lancet Respir Med; 2015 Mar; 3(3):179-80. PubMed ID: 25773208
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
